Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(19):1445-1447; doi:10.1093/jnci/93.19.1445-a
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Thompson, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thompson, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 19, 1445-1447, October 3, 2001
© 2001 Oxford University Press

NEWS

What Is the Promise of Embryonic Stem Cell Research?

Tracy Thompson

This August, U.S. President George W. Bush made the long-awaited announcement that he will permit federal funds to support research on the approximately 60 embryonic stem (ES) cell lines already in existence as of Aug. 9.

Since then, a debate about the usefulness, quality, characteristics, and availability of the 64 ES cell lines has ensued in the scientific community, in Congress, and in the pages of nearly every major newspaper and news magazine in the country. (See related story, p. 1447.)

As the moral, ethical, and legal debates continue, the fundamental question remains: Can ES cells live up to the expectation that they will be the building block of potentially miraculous cures? . . . [Full Text of this Article]

Stem Cell Successes in the Past

Autoimmune Diseases

Rebuilding the Nervous System

Heart Disease


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?